Literature DB >> 10364311

Failure To cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction.

T Zavorotinskaya1, L M Albritton.   

Abstract

It is thought that complete cleavage of retroviral envelope protein into mature surface protein (SU) and transmembrane protein (TM) is critical for its assembly into virions and the formation of infectious virus particles. Here we report the identification of highly infectious, cleavage-deficient envelope mutant proteins. Substitution of aspartate for lysine 104, arginines 124 and 126, or arginines 223 and 225 strongly suppressed cleavage of the envelope precursor and yet allowed efficient incorporation of precursor molecules as the predominant species in virions that were almost as infectious as the wild-type virus. These results indicate that cleavage of the envelope precursor into mature SU and TM is not necessary for assembly into virions. Moreover, they call into question how many mature envelope protein subunits are required to complete virus entry, suggesting that a very few molecules suffice. The failure of host cell proteases to cleave these mutant proteins, whose substitutions are distal to the actual site of cleavage, suggests that the envelope precursor is misfolded, sequestering the cleavage site. In agreement with this, all cleavage mutant proteins exhibited significant losses of receptor binding, suggesting that these residues play roles in proper envelope protein folding. We also identified a charged residue, arginine 102, whose substitution suppressed envelope cleavage and allowed precursor incorporation but resulted in virions that were virtually noninfectious and that exhibited the greatest reduction in receptor binding. Placement of these cleavage mutations into envelope proteins of targeted retroviral vectors for human gene therapy may prevent loss of the modified surface proteins from virions, improving their infectivity and storage hardiness.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364311      PMCID: PMC112620     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  The role of envelope glycoprotein processing in murine leukemia virus infection.

Authors:  E O Freed; R Risser
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

2.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

Authors:  A D Miller; C Buttimore
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

3.  A common progenitor for neurons and glia persists in rat retina late in development.

Authors:  D L Turner; C L Cepko
Journal:  Nature       Date:  1987 Jul 9-15       Impact factor: 49.962

4.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Identification of the fusion peptide of primate immunodeficiency viruses.

Authors:  M L Bosch; P L Earl; K Fargnoli; S Picciafuoco; F Giombini; F Wong-Staal; G Franchini
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

6.  Evidence for cooperation between murine leukemia virus Env molecules in mixed oligomers.

Authors:  A Rein; C Yang; J A Haynes; J Mirro; R W Compans
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  DNA methylation and gene expression: endogenous retroviral genome becomes infectious after molecular cloning.

Authors:  K Harbers; A Schnieke; H Stuhlmann; D Jähner; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

8.  Role of partial proteolysis in processing murine leukemia virus membrane envelope glycoproteins to the cell surface. A viral mutant with uncleaved glycoprotein.

Authors:  C A Machida; D Kabat
Journal:  J Biol Chem       Date:  1982-12-10       Impact factor: 5.157

9.  Characterization of murine-specific leukemia virus receptor from L cells.

Authors:  P A Johnson; M R Rosner
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

10.  Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus.

Authors:  J M McCune; L B Rabin; M B Feinberg; M Lieberman; J C Kosek; G R Reyes; I L Weissman
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

View more
  14 in total

1.  Efficient cell infection by Moloney murine leukemia virus-derived particles requires minimal amounts of envelope glycoprotein.

Authors:  E Bachrach; M Marin; M Pelegrin; G Karavanas; M Piechaczyk
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteins.

Authors:  Fang Li; Byoung Y Ryu; Robin L Krueger; Scott A Heldt; Lorraine M Albritton
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

3.  An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.

Authors:  J L Blond; D Lavillette; V Cheynet; O Bouton; G Oriol; S Chapel-Fernandes; B Mandrand; F Mallet; F L Cosset
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies.

Authors:  H Ito; S Watanabe; A Takada; Y Kawaoka
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses.

Authors:  L O'Reilly; M J Roth
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Amino acid residues in the cytoplasmic domain of the Mason-Pfizer monkey virus glycoprotein critical for its incorporation into virions.

Authors:  Chisu Song; Keith Micoli; Helena Bauerova; Iva Pichova; Eric Hunter
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  A hydrophobic patch in ecotropic murine leukemia virus envelope protein is the putative binding site for a critical tyrosine residue on the cellular receptor.

Authors:  T Zavorotinskaya; L M Albritton
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  Furin cleavage of the Moloney murine leukemia virus Env precursor reorganizes the spike structure.

Authors:  Mathilda Sjöberg; Shang-Rung Wu; Robin Löving; Kimmo Rantalainen; Birgitta Lindqvist; Henrik Garoff
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

9.  Two distinct mechanisms regulate recruitment of murine leukemia virus envelope protein to retroviral assembly sites.

Authors:  Tiffany M Lucas; Terri D Lyddon; Sarah A Grosse; Marc C Johnson
Journal:  Virology       Date:  2010-07-23       Impact factor: 3.616

10.  Identification of residues outside of the receptor binding domain that influence the infectivity and tropism of porcine endogenous retrovirus.

Authors:  Takele Argaw; Mariel Figueroa; Daniel R Salomon; Carolyn A Wilson
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.